Akebia Therapeutics (AKBA) Short Interest Ratio & Short Volume $1.80 -0.11 (-5.76%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.80 -0.01 (-0.28%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Akebia Therapeutics Short Interest DataAkebia Therapeutics (AKBA) has a short interest of 14.45 million shares. This marks a -19.68% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.4, indicating that it would take 6.4 days of the average trading volume of 2.22 million shares to cover all short positions.Current Short Interest14,450,000 sharesPrevious Short Interest17,990,000 sharesChange Vs. Previous Month-19.68%Dollar Volume Sold Short$32.37 millionShort Interest Ratio6.4 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares218,180,000 sharesPercentage of Shares Shorted6.62%Today's Trading Volume3,985,829 sharesAverage Trading Volume2,221,209 sharesToday's Volume Vs. Average179% Short Selling Akebia Therapeutics? Sign up to receive the latest short interest report for Akebia Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAKBA Short Interest Over TimeAKBA Days to Cover Over TimeAKBA Percentage of Float Shorted Over Time Akebia Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202514,450,000 shares $32.37 million -19.7%N/A6.4 $2.24 1/15/202517,990,000 shares $34.90 million +7.9%N/A7.3 $1.94 12/31/202416,680,000 shares $31.69 million +18.6%N/A7.9 $1.90 12/15/202414,070,000 shares $26.03 million +21.7%N/A7.1 $1.85 11/30/202411,560,000 shares $23.81 million -3.3%N/A6.2 $2.06 11/15/202411,960,000 shares $21.41 million -19.4%N/A6.5 $1.79 10/31/202414,840,000 shares $24.63 million -16.1%N/A8.1 $1.66 10/15/202417,680,000 shares $23.16 million -6.0%N/A10.6 $1.31 9/30/202418,800,000 shares $24.82 million -1.4%N/A10.1 $1.32 9/15/202419,060,000 shares $27.83 million -0.1%N/A7.2 $1.46 Get the Latest News and Ratings for AKBA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akebia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/202419,070,000 shares $29.56 million +0.6%N/A6.9 $1.55 8/15/202418,950,000 shares $27.29 million +5.9%N/A6.6 $1.44 7/31/202417,890,000 shares $24.69 million -4.1%N/A5.9 $1.38 7/15/202418,660,000 shares $24.44 million +42.3%N/A5.8 $1.31 6/30/202413,110,000 shares $13.37 million +6.6%N/A4 $1.02 6/15/202412,300,000 shares $13.16 million -6.5%N/A2.7 $1.07 5/31/202413,160,000 shares $14.74 million +12.5%N/A2.7 $1.12 5/15/202411,700,000 shares $13.81 million -1.4%N/A2.3 $1.18 4/30/202411,860,000 shares $14.94 million -13.4%N/A2.4 $1.26 4/15/202413,690,000 shares $19.03 million +2.2%N/A2.9 $1.39 3/31/202413,400,000 shares $24.52 million +32.3%N/A3 $1.83 3/15/202410,130,000 shares $17.22 million +24.9%N/A3.4 $1.70 2/29/20248,110,000 shares $12.81 million +1.4%N/A4 $1.58 2/15/20248,000,000 shares $11.76 million -8.9%N/A4.5 $1.47 1/31/20248,780,000 shares $14.75 million +12.1%N/A5.4 $1.68 1/15/20247,830,000 shares $12.14 million -0.5%N/A5 $1.55 12/31/20237,870,000 shares $9.76 million +7.4%N/A5.3 $1.24 12/15/20237,330,000 shares $8.43 million -18.7%N/A5.5 $1.15 11/30/20239,010,000 shares $9.55 million -8.8%N/A6.9 $1.06 11/15/20239,880,000 shares $9.88 million -4.3%N/A6.8 $1.00 10/31/202310,320,000 shares $9.08 million +33.2%N/A6.8 $0.88 10/15/20237,750,000 shares $7.03 million +6.5%N/A4.5 $0.91 9/30/20237,280,000 shares $8.30 million +0.7%N/A4.4 $1.14 9/15/20237,230,000 shares $9.11 million +24.4%N/A4.1 $1.26 8/31/20235,810,000 shares $8.08 million -14.1%N/A3.1 $1.39 8/15/20236,760,000 shares $8.86 million +10.3%N/A3.2 $1.31 7/31/20236,130,000 shares $10.24 million +13.7%N/A2.8 $1.67 7/15/20235,390,000 shares $5.71 million +11.4%N/A2.9 $1.06 6/30/20234,840,000 shares $4.43 million +11.3%N/A2.7 $0.92 6/15/20234,350,000 shares $4.96 million -15.5%N/A2.5 $1.14Here’s how you could profit from Elon’s NVIDIA partnership (Ad)"Elon's #1 AI Stock" SET TO SOAR Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world. Get all the details here >>> 5/31/20235,150,000 shares $5.36 million +26.5%N/A3 $1.04 5/15/20234,070,000 shares $4.44 million -9.6%N/A2.4 $1.09 4/30/20234,500,000 shares $4.09 million -20.8%N/A2.4 $0.91 4/15/20235,680,000 shares $3.57 million +0.4%N/A2.9 $0.63 3/31/20235,660,000 shares $3.17 million -15.3%N/A2.8 $0.56 3/15/20236,680,000 shares $4.49 million -20.3%N/A3 $0.67 2/28/20238,380,000 shares $7.06 million +82.6%N/A3.5 $0.84 2/15/20234,590,000 shares $4.07 million +38.3%N/A2 $0.89 1/31/20233,320,000 shares $2.09 million -28.1%N/A1.7 $0.63 1/15/20234,620,000 shares $3.21 million -0.9%N/A2.7 $0.70 12/30/20224,660,000 shares $2.69 million -0.4%N/A2.7 $0.58 12/15/20224,680,000 shares $2.12 million -2.9%N/A3.1 $0.45 11/30/20224,820,000 shares $1.30 million -12.5%N/A3.4 $0.27 11/15/20225,510,000 shares $1.41 million -6.9%N/A3.8 $0.26 10/31/20225,920,000 shares $1.51 million -5.9%N/A3.4 $0.25 10/15/20226,290,000 shares $1.82 million -13.4%N/A2.7 $0.29 9/30/20227,260,000 shares $2.30 million -5.8%N/A2.6 $0.32 9/15/20227,710,000 shares $2.85 million -3.5%N/A1.1 $0.37 8/31/20227,990,000 shares $2.91 million -14.5%N/A1 $0.36 8/15/20229,340,000 shares $3.87 million -18.5%N/A1 $0.41 7/31/202211,460,000 shares $4.48 million +1.4%N/A1.1 $0.39 7/15/202211,300,000 shares $4.77 million +19.5%N/A1 $0.42 6/30/20229,460,000 shares $3.34 million -39.6%N/A0.7 $0.35 6/15/202215,660,000 shares $5.53 million -11.9%N/A1.2 $0.35 5/31/202217,780,000 shares $6.58 million -8.1%N/A1.5 $0.37 5/15/202219,340,000 shares $8.68 million +1.2%N/A1.8 $0.45 4/30/202219,120,000 shares $7.94 million +12.3%N/A1.9 $0.42 4/15/202217,020,000 shares $9.16 million -20.5%N/A1.9 $0.54 3/31/202221,410,000 shares $15.37 million +44.1%N/A3 $0.72 3/15/202214,860,000 shares $34.18 million +12.9%N/A3.8 $2.30 2/28/202213,160,000 shares $28.43 million +7.6%N/A3.5 $2.16 2/15/202212,230,000 shares $22.38 million +9.0%N/A3.6 $1.83 1/31/202211,220,000 shares $22.33 million +9.9%N/A3.5 $1.99 1/15/202210,210,000 shares $22.46 million -10.0%N/A3.4 $2.20 12/31/202111,350,000 shares $25.65 million -4.2%N/A4.1 $2.26 12/15/202111,850,000 shares $29.03 million +4.1%N/A4.6 $2.45 11/30/202111,380,000 shares $30.84 million +10.3%N/A5.5 $2.71 11/15/202110,320,000 shares $29.62 million -11.2%N/A5.1 $2.87 10/29/202111,620,000 shares $33.35 million +1.9%N/A5.8 $2.87 10/15/202111,400,000 shares $32.49 million -10.2%N/A5.3 $2.85 9/30/202112,690,000 shares $36.55 million +1.5%N/A4.1 $2.88 9/15/202112,500,000 shares $34.75 million -6.6%N/A3.9 $2.78 8/31/202113,380,000 shares $39.34 million +2.8%N/A3.7 $2.94 8/13/202113,010,000 shares $32.79 million -6.9%N/A3.4 $2.52 7/30/202113,980,000 shares $34.53 million -11.0%N/A3.6 $2.47 7/15/202115,700,000 shares $52.12 million +2.9%10.3%4.1 $3.32 6/30/202115,260,000 shares $57.84 million -2.2%10.0%4.6 $3.79 6/15/202115,610,000 shares $54.95 million -3.0%10.2%4.5 $3.52 5/28/202116,090,000 shares $56.48 million -11.7%10.6%4.5 $3.51 5/14/202118,220,000 shares $60.67 million -0.3%N/A4.3 $3.33Here’s how you could profit from Elon’s NVIDIA partnership (Ad)"Elon's #1 AI Stock" SET TO SOAR Forget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful. After all, ChatGPT just works online... While Elon's AI works in the real world. Get all the details here >>> 4/30/202118,280,000 shares $59.41 million -7.2%N/A3.6 $3.25 4/15/202119,690,000 shares $61.33 million -7.6%N/A3.3 $3.12 3/31/202121,300,000 shares $65.92 million -15.2%N/A3.3 $3.10 3/15/202125,130,000 shares $90.72 million -1.5%N/A3.7 $3.61 2/26/202125,500,000 shares $88.49 million -3.2%N/A3.7 $3.47 2/12/202126,350,000 shares $125.69 million -4.0%N/A4 $4.77 1/29/202127,450,000 shares $94.02 million -4.8%N/A4.4 $3.43 1/15/202128,820,000 shares $91.36 million +0.5%N/A4.5 $3.17 12/31/202028,680,000 shares $85.75 million +20.9%N/A4.4 $2.99 12/15/202023,730,000 shares $75.46 million +0.8%N/A3.7 $3.18 11/30/202023,540,000 shares $79.80 million -6.2%N/A3.3 $3.39 11/15/202025,100,000 shares $63.75 million -6.1%N/A3 $2.54 10/30/202026,730,000 shares $60.68 million +7.7%N/A3.4 $2.27 10/15/202024,830,000 shares $88.89 million +12.0%N/A3.7 $3.58 9/30/202022,170,000 shares $55.65 million +141.8%N/A4.3 $2.51 9/15/20209,170,000 shares $24.21 million +12.4%N/A2 $2.64 8/31/20208,160,000 shares $84.95 million -10.0%N/A2.4 $10.41 8/14/20209,070,000 shares $95.51 million -5.2%N/A6.9 $10.53 7/31/20209,570,000 shares $106.90 million -1.8%N/A6.5 $11.17 7/15/20209,740,000 shares $120.29 million +1.0%N/A5.6 $12.35 6/30/20209,640,000 shares $122.43 million +61.5%N/A5.5 $12.70 6/15/20205,970,000 shares $72.42 million +18.5%N/A3.7 $12.13 5/29/20205,040,000 shares $58.67 million -21.3%N/A3 $11.64 5/15/20206,400,000 shares $79.49 million -16.0%N/A3.7 $12.42 4/30/20207,620,000 shares $61.72 million +3.8%N/A4.6 $8.10 4/15/20207,340,000 shares $53.36 million +8.3%N/A5.3 $7.27 3/31/20206,780,000 shares $52.27 million -6.5%5.8%4.4 $7.71 3/13/20207,251,800 shares $50.76 million -2.4%7.0%4.2 $7.00 2/28/20207,430,000 shares $46.29 million -5.6%7.2%5.3 $6.23 AKBA Short Interest - Frequently Asked Questions What is Akebia Therapeutics' current short interest? Short interest is the volume of Akebia Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 14,450,000 shares of AKBA short. Learn More on Akebia Therapeutics' current short interest. What is a good short interest ratio for Akebia Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKBA shares currently have a short interest ratio of 6.0. Learn More on Akebia Therapeutics's short interest ratio. Which institutional investors are shorting Akebia Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Akebia Therapeutics: Wolverine Trading LLC, Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Akebia Therapeutics' short interest increasing or decreasing? Akebia Therapeutics saw a decrease in short interest in January. As of January 31st, there was short interest totaling 14,450,000 shares, a decrease of 19.7% from the previous total of 17,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Akebia Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Akebia Therapeutics: NewAmsterdam Pharma (4.62%), IDEAYA Biosciences, Inc. (12.38%), Schrödinger, Inc. (13.72%), Travere Therapeutics, Inc. (12.25%), Belite Bio, Inc (0.20%), Vera Therapeutics, Inc. (16.56%), Iovance Biotherapeutics, Inc. (26.04%), Praxis Precision Medicines, Inc. (15.21%), Galapagos NV (2.65%), Wave Life Sciences Ltd. (6.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Akebia Therapeutics stock? Short selling AKBA is an investing strategy that aims to generate trading profit from Akebia Therapeutics as its price is falling. AKBA shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Akebia Therapeutics? A short squeeze for Akebia Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AKBA, which in turn drives the price of the stock up even further. How often is Akebia Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKBA, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies NAMS Short Interest Data IDYA Short Interest Data SDGR Short Interest Data TVTX Short Interest Data BLTE Short Interest Data VERA Short Interest Data IOVA Short Interest Data PRAX Short Interest Data GLPG Short Interest Data WVE Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AKBA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akebia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akebia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKBA Stock Alerts